Trilobio

About:

Robotics & Synthetic Biology

Website: https://trilo.bio/

Twitter/X: trilobio

Top Investors: Lowercarbon Capital, 1517 Fund, Argon Ventures, Nucleus Capital, Climate Capital Bio

Description:

Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab protocols as code. The goal is to deploy fully automated labs that dramatically improve data quality and reproducibility.

Total Funding Amount:

$3M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2021-09-21

Contact Email:

hello(AT)trilo.bio

Founders:

Maximilian Schommer, Roya Amini-Naieni

Number of Employees:

1-10

Last Funding Date:

2023-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai